Dr. Paul David Gittelman, MD

Dr. Gittelman practices at ENT and Allergy Associates in Purchase, New York.

Dr. Gittelman's NPI, 1689761686, was assigned on October 10, 2006. Dr. Gittelman graduated from New York Medical College in 1983. Dr. Gittelman holds New York license 158598.

Dr. Gittelman's primary practice is ENT and Allergy Associates, at 3020 Westchester Ave, Purchase, NY 10577 in Westchester County. The practice phone is (914) 333-5800.

Dr. Gittelman's primary practice is ENT and Allergy Associates in Purchase, New York. Dr. Gittelman is also affiliated with Burke Rehabilitation Hospital. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Gittelman to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gittelman practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Gittelman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Gittelman is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Gittelman's licenses on file in 3 states: New York, New Jersey and Connecticut.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Gittelman treats.

CMS data shows 2,353 Medicare services from Dr. Gittelman across 13 procedure codes in 2024, for 546 Medicare patients. Medicare paid $219,872 for them. Every service was in an office.

CMS counts 546 Medicare patients who saw Dr. Gittelman in 2024. The largest group is 75 to 84, with 219 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gittelman's median patient age at 59, with 52% women.

In 2024, Dr. Gittelman wrote 664 Medicare Part D claims for 268 patients. 97% of them were for generic drugs. CMS names the drug for 570 of them, across 13 drugs with 11 or more claims each, at $14,878 in total drug cost. In 2023, CMS named 587 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Gittelman for performance year 2024, reported as part of a group. Dr. Gittelman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Gittelman.

CMS Open Payments shows 365 general payments to Dr. Gittelman from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $1,123.

Dmand AI lists 2 awards for Dr. Gittelman.

Dr. Gittelman graduated from New York Medical College in 1983. Dr. Gittelman is a member of NHS and ACS.

Dr. Gittelman is in network with 12 carriers, including Elevance, Aetna and MVP Health Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.